sever
acut
respiratori
syndrom
sar
signific
emerg
infecti
diseas
human
infect
etiolog
agent
sarsassoci
coronaviru
sarscov
primarili
present
pneumon
may
also
develop
hepat
gastrointestin
renal
patholog
inocul
common
marmoset
callithrix
jacchu
object
develop
small
nonhuman
primat
model
sar
two
group
c
jacchu
inocul
intratrach
cell
cultur
supernat
contain
sarscov
time
cours
pathogenesi
studi
anim
evalu
day
infect
morpholog
chang
evid
viral
replic
anim
develop
multifoc
mononuclear
cell
interstiti
pneumon
accompani
multinucl
syncyti
cell
edema
bronchiol
anim
viral
antigen
local
primarili
infect
alveolar
macrophag
pneumocyt
immunohistochemistri
viral
rna
detect
anim
pulmonari
tissu
extract
obtain
necropsi
viral
rna
also
detect
tracheobronchi
lymph
node
myocardium
togeth
inflammatori
chang
anim
hepat
inflamm
observ
anim
predominantli
multifoc
lymphocyt
hepat
accompani
necrosi
individu
hepatocyt
find
identifi
common
marmoset
promis
nonhuman
primat
studi
sarscov
pathogenesi
j
pathol
sever
acut
respiratori
syndrom
sar
signific
emerg
infecti
diseas
human
infect
etiolog
agent
sarsassoci
coronaviru
sarscov
primarili
present
pneumon
may
also
develop
hepat
gastrointestin
renal
patholog
inocul
common
marmoset
callithrix
jacchu
object
develop
small
nonhuman
primat
model
sar
two
group
c
jacchu
inocul
intratrach
cell
cultur
supernat
contain
sarscov
time
cours
pathogenesi
studi
anim
evalu
day
infect
morpholog
chang
evid
viral
replic
anim
develop
multifoc
mononuclear
cell
interstiti
pneumon
accompani
multinucl
syncyti
cell
edema
bronchiol
anim
viral
antigen
local
primarili
infect
alveolar
macrophag
pneumocyt
immunohistochemistri
viral
rna
detect
anim
pulmonari
tissu
extract
obtain
necropsi
viral
rna
also
detect
tracheobronchi
lymph
node
myocardium
togeth
inflammatori
chang
anim
hepat
inflamm
observ
anim
predominantli
multifoc
lymphocyt
hepat
accompani
necrosi
individu
hepatocyt
find
identifi
common
marmoset
promis
nonhuman
primat
studi
sarscov
pathogenesi
j
pathol
outbreak
emerg
infecti
diseas
sever
acut
respiratori
syndrom
sar
began
novemb
eventu
contain
juli
mean
extens
impress
coordin
worldwid
effort
diagnos
infect
individu
provid
care
contain
effort
involv
dedic
clinic
caretak
public
health
agenc
research
laboratori
end
epidem
probabl
case
sar
nearli
death
human
sar
primarili
present
pneumon
mortal
primarili
attribut
respiratori
failur
relat
complic
mani
studi
document
organ
like
involv
signific
way
initi
clinic
find
pneumon
care
monitor
individu
includ
diarrhea
patient
lymphocytopenia
patient
abnorm
plasma
concentr
liver
enzym
patient
cardiac
failur
list
clinic
sign
case
report
unusu
present
abnorm
urinalys
correl
viral
shed
urin
primari
function
receptor
sarscov
angiotensin
convert
metalloproteinas
involv
hemodynam
homeostasi
express
tissu
distribut
larg
pulmonari
intestin
epitheli
cell
primarili
concord
histopatholog
obtain
autopsi
individu
succumb
infect
human
diseas
mark
primarili
viral
shed
respiratori
gastrointestin
tract
viruria
detect
signific
proport
infect
individu
suggest
renal
tubular
epitheli
cell
express
infect
also
express
high
level
vascular
endotheli
cell
find
may
explain
inflammatori
chang
organ
system
vascul
observ
individu
viral
rna
demonstr
liver
lymph
node
spleen
heart
skelet
muscl
studi
fatal
sar
viremia
detect
albeit
inconsist
yet
report
demonstr
infect
vascular
endotheli
cell
sarscov
identifi
genom
fulli
sequenc
month
world
health
organ
global
alert
ultim
demonstr
sarscov
infect
diseas
primat
provid
element
koch
postul
prove
causal
reproduc
sarscovrel
pneumon
old
world
primat
speci
somewhat
problemat
infect
anim
rare
show
clinic
sign
diseas
viru
concentr
tissu
tend
rel
low
small
anim
proven
use
studi
efficaci
certain
intervent
includ
balbc
mous
syrian
hamster
ferret
murin
model
histopatholog
minim
despit
rel
high
viral
concentr
lung
tissu
reliabl
reduct
viral
titer
demonstr
effect
vaccin
neutral
antibodi
syrian
hamster
develop
consolid
pneumon
resolv
within
week
ferret
develop
patchi
pneumon
along
hepat
latter
two
anim
model
shown
promis
measur
effect
vaccin
therapeut
also
use
evalu
risk
diseas
enhanc
reason
small
nonhuman
primat
model
sar
would
use
research
tool
studi
pathogenesi
vaccin
therapeut
perform
pilot
studi
common
marmoset
c
jacchu
select
anim
studi
small
size
g
avail
larg
breed
coloni
suscept
variou
human
respiratori
virus
rel
wealth
reagent
immunohistochemistri
flow
cytometri
inform
regard
immunolog
isol
sarscov
use
studi
urbani
strain
kindli
provid
larri
anderson
center
diseas
control
atlanta
ga
low
passag
stock
gener
growth
vero
cell
medium
dulbecco
modifi
eagl
medium
fetal
calf
serum
gentamicin
infecti
titer
determin
use
vero
cell
microtit
plate
describ
anim
c
jacchu
bred
hous
new
england
primat
research
center
accord
harvard
medic
school
stand
committe
anim
guid
care
use
laboratori
anim
nation
academi
press
clinic
husbandri
techniqu
previous
describ
experi
anim
move
acclimat
anim
biosafeti
level
facil
experiment
inocul
inocul
anim
anesthet
intub
tracheal
flexibl
polyethylen
cathet
l
cell
cultur
supernat
infect
uninfect
infiltr
two
group
six
juvenil
young
adult
c
jacchu
intratrach
inocul
l
cell
cultur
supernat
contain
tcid
urbani
strain
sarscov
time
cours
pathogenesi
studi
anim
evalu
day
inocul
morpholog
chang
evid
viral
replic
anim
euthan
day
inocul
intraven
administr
mgkg
na
pentobarbit
necropsi
perform
new
england
primat
research
center
euthanasia
complet
necropsi
perform
tissu
collect
neutral
buffer
formalin
repres
tissu
paraffinembed
section
stain
hematoxylin
eosin
routin
evalu
immunohistochemistri
quantit
imag
analysi
use
character
immunophenotyp
composit
inflammatori
cell
infiltr
observ
lung
tissu
local
viral
antigen
immunohistochemistri
perform
use
avidinbiotinhorseradish
peroxidas
complex
techniqu
dab
chromogen
dako
carpinteria
ca
previous
describ
briefli
section
tissu
label
use
monoclon
antibodi
hladr
tcell
intracytoplasm
antigen
examin
olympu
vanox
ahb
microscop
interfac
leica
qwin
imag
analysi
system
leica
imag
system
cambridg
uk
via
dei
chargecoupl
devic
camera
optron
goleta
ca
local
viral
antigen
immunohistochemistri
perform
use
rabbit
antisar
surfac
glycoprotein
polyclon
serum
rabbit
immun
recombin
sglycoprotein
ectodomain
develop
human
monoclon
antibodi
serum
anim
high
sarscov
neutral
titer
effect
concentr
dilut
use
studi
section
formalinfix
paraffinembed
tissu
stain
serum
dilut
minut
room
temperatur
primari
antibodi
detect
biotinyl
goat
antirabbit
secondari
antibodi
vector
laboratori
burlingam
ca
dilut
follow
abc
immunostain
vector
laboratori
util
dab
chromogen
dako
control
nonspecif
stain
includ
section
sarsinfect
marmoset
stain
rabbit
preimmun
serum
collect
immun
rabbit
recombin
sglycoprotein
section
mockinfect
marmoset
stain
rabbit
antisglycoprotein
serum
quantit
revers
transcriptas
rt
polymeras
chain
reaction
pcr
use
examin
viral
load
biolog
specimen
tissu
obtain
necropsi
viral
rna
extract
specimen
use
qiaamp
viral
rna
rneasi
kit
accord
manufactur
protocol
qiagen
inc
valencia
ca
rna
quantit
perform
roch
lightcycl
instrument
roch
appli
scienc
indianapoli
roch
sarscov
artu
realart
hpacoronaviru
quantit
kit
accord
manufactur
instruct
roch
diagnost
indianapoli
artu
biotech
hamburg
germani
report
hourfar
colleagu
found
artu
realart
assay
greater
sensit
roch
assay
accur
quantifi
lower
concentr
rna
anim
hous
facil
certifi
harvard
medic
school
commiss
microbiolog
safeti
exce
requir
biosafeti
microbiolog
biomed
laboratori
center
diseas
controln
institut
health
personnel
handl
infect
anim
use
power
airpurifi
respir
papr
clinic
procedur
includ
necropsi
perform
biocontain
glove
box
univers
massachusett
medic
school
personnel
use
papr
laboratori
process
infect
sampl
effort
minim
risk
aerosol
format
two
differ
method
tissu
homogen
allow
tissu
disrupt
seal
vessel
test
use
stomach
lab
blender
seward
norfolk
uk
first
experi
mini
beadbeat
horizont
shaker
biospec
product
bartlesvil
ok
second
experi
tissu
flashfrozen
thaw
weigh
minc
place
sealabl
contain
bag
tube
medium
final
concentr
wv
antibiot
accord
subbarao
colleagu
beadbeat
process
tube
halffil
zirconium
bead
type
tissu
disrupt
process
perform
highest
set
minut
rneasi
mini
kit
adapt
direct
rna
extract
lung
tissu
use
mini
beadbeat
accord
manufactur
instruct
qiagen
group
compar
statist
use
commerci
avail
softwar
sigma
stat
jandel
scientif
ttest
mannwhitney
rank
sum
test
appropri
anim
model
sarscov
infect
clinic
sign
gener
mild
inocul
tabl
anim
continu
eat
remain
activ
howev
statist
signific
increas
rectal
temperatur
anim
day
inocul
although
increas
bodi
temperatur
rel
modest
anim
anesthet
physic
exam
commonli
lower
bodi
temperatur
activ
anim
wateri
nonhemorrhag
diarrhea
develop
anim
inocul
two
anim
develop
dyspnea
anesthesia
day
first
experi
subtl
clear
evid
diseas
lung
specimen
day
grossli
lung
vari
normal
appear
multifoc
area
atelectasi
consolid
tracheobronchi
lymphadenopathi
observ
two
anim
otherwis
gross
anatom
patholog
observ
heart
spleen
liver
kidney
gastrointestin
tract
anim
develop
pneumonia
character
multifoc
coalesc
interstiti
pneumon
tabl
day
infect
infiltr
mild
character
increas
number
neutrophil
within
septal
wall
day
infect
interstiti
diseas
predominantli
mononuclear
accompani
variabl
increas
number
alveolar
macrophag
exud
figur
b
hyalin
membran
rare
observ
howev
multinucl
syncytia
first
appar
time
figur
day
infect
pneumon
appear
resolv
anim
edema
observ
patchi
distribu
tion
other
pulmonari
inflamm
persist
accompani
consolid
alveolar
space
prolifer
type
ii
pneumocyt
figur
microscop
tracheobronchi
lymph
node
enlarg
associ
parafollicular
lymphocyt
hyperplasia
histiocytosi
within
subcapsular
sinus
given
small
number
anim
time
point
possibl
reach
conclus
peak
patholog
anim
appear
pneumon
resolv
day
two
anim
absent
mild
moder
sever
greatest
amount
diseas
euthan
day
tabl
control
rule
nonspecif
reactiv
compon
cultur
medium
two
anim
mock
infect
vero
cultur
supernat
euthan
day
infect
remain
healthi
neither
develop
pneumon
addit
interstiti
pneumon
airway
patholog
observ
anim
later
time
point
also
involv
termin
respiratori
bronchiol
figur
mild
lymphocyt
infiltr
observ
submucosa
accompani
loss
irregular
surfac
respiratori
epitheli
cell
two
anim
lymphocyt
perivascular
infiltr
also
appar
one
anim
find
strike
accompani
sever
coalesc
interstiti
pneumonia
figur
immunohistochemistri
perform
local
viru
character
inflammatori
cell
infiltr
within
pulmonari
tissu
viru
antigen
sglycoprotein
observ
multinucl
syncyti
cell
alveoli
type
pneumocyt
macrophag
also
posit
viral
antigen
express
anim
figur
viral
antigen
observ
hepat
intestin
renal
dermal
tissu
immunohistochemistri
reveal
inflammatori
infiltr
compos
primarili
macrophag
smaller
number
lymphocyt
increas
express
mhc
ii
antigen
hladr
observ
foci
inflamm
day
hepat
inflammatori
cell
infiltr
observ
anim
earliest
time
point
day
inocul
character
small
aggreg
mononuclear
cell
within
hepat
sinusoid
occasion
coalesc
form
multifoc
hepat
figur
day
infect
hepat
readili
appar
four
five
anim
examin
wellform
lymphocyt
inflammatori
cell
infiltr
associ
death
individu
hepatocyt
appear
round
dens
eosinophil
figur
b
c
day
infect
anim
evid
multifoc
hepat
superimpos
pattern
anim
hepat
lesion
multifoc
inflammatori
process
center
hepat
vein
figur
pattern
character
mononuclear
cell
cuff
variabl
thick
extend
adjac
hepat
parenchyma
associ
death
individu
hepatocyt
occasion
process
associ
fewer
expect
endotheli
cell
fibrin
deposit
vessel
surfac
anim
pulmonari
perivascul
also
hepat
lesion
immunostain
demonstr
hladr
express
inflammatori
cell
infiltr
preponder
cell
stain
posit
consist
cytolyt
lymphocyt
nk
cell
figur
e
f
mild
diffus
coliti
appar
anim
correl
clinic
sign
diarrhea
mark
colon
crypt
epitheli
cell
hyperplasia
character
loss
goblet
cell
cytoplasm
basophilia
loss
nuclear
polar
evid
enteropathogen
escherichia
coli
epec
observ
microscop
four
anim
coliti
epec
common
enter
pathogen
marmoset
thu
find
diarrhea
coliti
may
result
infect
concurr
pathogen
neither
diarrhea
coliti
observ
mockinfect
anim
mild
multifoc
lymphocyt
myocard
observ
three
anim
pronounc
anim
examin
day
renal
patholog
evid
specimen
time
point
anim
experi
found
tissu
disrupt
ineffici
use
stomach
larger
volum
medium
requir
result
homogen
rel
low
concentr
necessari
concentr
sampl
use
centricon
column
millipor
billerica
improv
yield
pcr
assay
viru
isol
titrat
attempt
howev
viral
growth
detect
sampl
includ
oral
swab
rectal
swab
tissu
homogen
first
group
six
anim
despit
sampleprocess
limit
describ
viral
rna
detect
tissu
homogen
two
six
anim
one
anim
high
concentr
sarscov
rna
lung
copiesg
tissu
detect
rna
tracheobronchi
lymph
node
heart
tissu
day
infect
anim
high
concentr
viral
rna
one
two
lung
sampl
day
mini
beadbeat
enabl
use
smaller
volum
anim
experi
result
gener
higher
tissu
homogen
concentr
also
observ
greater
tissu
disrupt
achiev
compar
first
experi
mini
beadbeat
protocol
easili
adapt
direct
rna
extract
tissu
even
greater
sensit
detect
viral
rna
given
cultur
result
initi
experi
focus
primarili
viral
rna
detect
quantif
second
experi
viral
rna
detect
lung
tissu
sampl
six
anim
viral
rna
concentr
rang
undetect
detect
thresh
old
valu
rang
copiesg
tissu
copiesg
tissu
multipl
lung
sampl
taken
anim
necropsi
indic
wide
variat
viral
rna
concentr
differ
area
lung
figur
overal
greater
fraction
specimen
posit
day
day
averag
peak
concentr
viral
rna
higher
day
day
tabl
differ
reach
statist
signific
two
anim
no
detect
viral
rna
tracheobronchi
lymph
node
heart
one
viral
rna
heart
viral
rna
detect
hepat
intestin
homogen
howev
extract
intestin
homogen
half
hepat
homogen
inhibitori
pcr
assay
nest
pcr
reaction
detect
viral
rna
also
gave
neg
result
liver
homogen
data
shown
common
marmoset
c
jacchu
small
new
world
nonhuman
primat
distinct
advantag
infecti
diseas
research
shown
experi
c
jacchu
suscept
sarscov
infect
develop
pulmonari
patholog
princip
character
multifoc
interstiti
pneumon
multinucl
syncyti
cell
accompani
lymphocyt
bronchiol
earli
time
point
viral
replic
demonstr
pulmonari
tissu
immunohistochemistri
rtpcr
note
pilot
experi
undoubtedli
underestim
concentr
sarscov
tissu
biolog
specimen
effort
minim
potenti
aerosol
format
like
limit
yield
viru
tissu
reason
find
compar
directli
studi
use
differ
techniqu
tissu
disrupt
rna
extract
sensit
techniqu
current
use
measur
viral
concentr
although
pulmon
diseas
predomin
histolog
evid
addit
organ
system
involv
exist
cardiac
lymphoid
hepat
tissu
data
provid
direct
evid
viru
present
lymphoid
cardiac
tissu
presenc
inflamm
liver
heart
bowel
suggest
anim
model
sar
share
featur
extrapulmonari
diseas
commonli
found
human
human
gener
good
concord
express
primari
function
receptor
sarscov
associ
patholog
distribut
viral
rna
presenc
inflamm
andor
sarscov
rna
similar
tissu
distribut
marmoset
suggest
express
level
similar
human
import
lsign
less
effici
function
receptor
sarscov
yet
defin
could
studi
anim
model
hepat
lesion
conspicu
find
anim
inocul
elev
liver
enzym
hepat
lesion
also
describ
clinic
entiti
human
patient
infect
sarscov
viral
rna
demonstr
hepat
tissu
individu
sar
hepatocyt
express
sarscov
nprotein
demonstr
fatal
case
sar
pattern
earli
appear
lesion
marmoset
suggest
direct
viral
infect
hepatocyt
may
play
role
unabl
demonstr
viral
antigen
viral
rna
hepat
tissu
use
reagent
techniqu
avail
time
direct
evid
sampl
inhibit
limit
abil
amplifi
gene
product
hepat
tissu
rna
extract
direct
infect
hepatocyt
yet
unproven
remain
lead
hypothesi
hepat
observ
sarscovinfect
marmoset
hypothesi
test
futur
studi
use
differ
techniqu
rna
extract
gene
amplif
differ
antibodi
immunohistochemistri
effort
enhanc
sensit
altern
hypothesi
would
trigger
crossreact
autoimmun
respons
consid
less
like
given
presenc
lesion
anim
rel
lack
similar
inflammatori
cell
infiltr
organ
eg
kidney
recent
promin
hepat
lesion
found
ferret
model
vaccin
subsequ
sarscov
challeng
greater
sever
hepat
immun
anim
suggest
immun
enhanc
patholog
enhanc
patholog
describ
coronaviru
infect
repeat
exposur
implic
design
vaccin
therapeut
intervent
sar
rapid
appear
random
mononuclear
hepat
infect
marmoset
might
point
toward
innat
immun
respons
infiltr
nk
cell
pattern
observ
mice
infect
mcmv
peak
level
observ
second
day
infect
howev
expand
pattern
hepat
lesion
day
latest
time
point
pilot
studi
presenc
cytolyt
lymphocyt
aggreg
activ
cell
express
hladr
would
also
consist
virusspecif
recognit
lymphocyt
infect
cell
scatter
hepat
parenchyma
line
hepat
vein
enhanc
sarscovinduc
hepat
vaccin
ferret
would
also
consist
earlier
pronounc
accumul
virusspecif
lymphocyt
site
viru
replic
addit
studi
requir
determin
whether
preexist
immun
alter
hepat
patholog
marmoset
although
infect
common
marmoset
mimic
aspect
primari
sarscov
infect
man
diffus
alveolar
damag
hallmark
morpholog
featur
sar
observ
throughout
time
cours
evalu
epidemiolog
studi
indic
may
rang
diseas
sever
human
patient
advanc
age
concurr
diseas
diabet
clear
risk
factor
develop
diffus
alveolar
damag
studi
focus
earli
event
sarscov
infect
use
juvenil
young
adult
anim
studi
longer
durat
util
anim
differ
age
group
help
determin
whether
aspect
sarscov
infect
may
appropri
studi
use
speci
addit
studi
necessari
understand
complet
diseas
cours
manifest
variabl
exist
infect
anim
may
problemat
also
potenti
valuabl
defin
determin
diseas
cours
larger
nonhuman
primat
test
suffici
larg
number
defin
host
characterist
influenc
pathogenesi
small
nonhuman
primat
model
like
use
tool
investig
aspect
pathogenesi
common
marmoset
particularli
well
suit
defin
immunolog
correl
diseas
conclus
demonstr
common
marmoset
suscept
sarscov
infect
develop
diseas
share
featur
sar
human
absenc
diseas
outbreak
current
case
sar
nonhuman
primat
model
pathogenesi
treatment
becom
increasingli
import
base
promis
preliminari
data
believ
common
marmoset
serv
use
surrog
system
assess
treatment
efficaci
critic
host
determin
pathogenesi
defin
anim
model
relev
human
diseas
may
better
defin
type
analys
enhanc
understand
diseas
process
allow
effici
test
vaccin
variou
treatment
modal
common
marmoset
